Clinical Trial Update: Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

View source ↗

Summary

This trial update presents a retrospective analysis of the effectiveness of caplacizumab in treating acquired thrombotic thrombocytopenic purpura (aTTP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• CABLIVI (CAPLACIZUMAB)

Snippet

Sponsor: University of Cologne | Conditions: Acquired Thrombotic Thrombocytopenic Purpura | Status: RECRUITING